An FDA warning to pharma company regarding their promo material; Entresto’s approval is expanded; There’s approvals in homozygous familial hypercholesterolemia and chronic inflammatory demyelinating polyneuropathy; And a migraine device is OK’d for teens.
Second study shows no association for use of macrolides during pregnancy with increase in major birth defects.
The Company will have 15 days from the date of receipt of the letter to address these concerns and provide the Agency with a plan of action.
Findings from an adolescent study showed that 46.8% of treated attacks were successfully resolved without the use of any acute rescue medication.
To learn more about the overlapping crises of the opioid epidemic and the COVID-19 pandemic, Psychiatry Advisor interviewed pain specialist Paul J. Christo, MD, MBA, the Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital in Baltimore, Maryland.
Patients with history suggestive of aberrant opioid use have even harder time getting an appointment
MAST MMPR regimen includes oral acetaminophen, naproxen, gabapentin, lidocaine patches, and as-needed opioids
This week we take a look at the remaining prospective COVID vaccines, that includes AstraZeneca, J&J and Novovax; There’s also drug approvals for analgesia and influenza.
For light sedation of mechanically ventilated patients with sepsis, number of days alive without delirium or coma similar between groups
Investigators assessed the efficacy and tolerability of a high-concentration capsaicin 8% patch to treat diabetic peripheral nerve pain, either alone or in combination with standard oral therapies.
